Chemoinformaics analysis of Carumbelloside II
| Molecular Weight | 494.625 | nRot | 4 |
| Heavy Atom Molecular Weight | 452.289 | nRig | 18 |
| Exact Molecular Weight | 494.288 | nRing | 5 |
| Solubility: LogS | -3.573 | nHRing | 1 |
| Solubility: LogP | 2.78 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 77 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
| nHA | 8 | APOL | 79.5113 |
| nHD | 5 | BPOL | 46.4747 |
| QED | 0.511 |
| Synth | 2.528 |
| Natural Product Likeliness | 1.424 |
| NR-PPAR-gamma | 0.929 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.378 |
| HIA | 0.028 |
| CACO-2 | -5.007 |
| MDCK | 0.00000938 |
| BBB | 0.015 |
| PPB | 0.962509 |
| VDSS | 0.497 |
| FU | 0.0428135 |
| CYP1A2-inh | 0.978 |
| CYP1A2-sub | 0.115 |
| CYP2c19-inh | 0.109 |
| CYP2c19-sub | 0.045 |
| CYP2c9-inh | 0.581 |
| CYP2c9-sub | 0.843 |
| CYP2d6-inh | 0.561 |
| CYP2d6-sub | 0.416 |
| CYP3a4-inh | 0.619 |
| CYP3a4-sub | 0.075 |
| CL | 9.175 |
| T12 | 0.885 |
| hERG | 0.083 |
| Ames | 0.218 |
| ROA | 0.063 |
| SkinSen | 0.952 |
| Carcinogencity | 0.088 |
| EI | 0.944 |
| Respiratory | 0.179 |
| NR-Aromatase | 0.842 |
| Antiviral | Yes |
| Prediction | 0.818821 |